Fingerprint
Dive into the research topics of 'MK-2206 and standard neoadjuvant chemotherapy improves response in patients with human epidermal growth factor receptor 2–positive and/or hormone receptor–negative breast cancers in the I-SPY 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically